Table 6.
Effects of herbal formulation addition on disease outcome
| Treatment outcome for ATT | Control | Trial | P |
| Number of sputum +ve case at start (%) | 67/192 (35) | 137/316 (43) | 0.03 |
| Number of sputum +ve case after 1-month of treatment (%) | 10/67 (14.93) | 4/137 (2.9) | 0.0068 |
| Poorly resolved parenchymal lesion (%) | 9/152 (5.92) | 2/258 (0.78) | 0.0037 |
| Failure to improve functional status (%) | 19/192 (10) | 6/316 (2) | 0.00013 |
| Treatment dropouts (%) | 10/192 (5.2) | 0 | 0.0001 |
| Weight (kg) | 39.17 ± 5.5 | 40.65 ± 6.22 | 0.0016 |
| Hb (%) | 10.92 ± 2.01 | 11.17 ± 1.97 | 0.176 |
| ESR mm in 1st hour | 45.96 ± 18.52 | 38.84 ± 22.37 | 0.0001 |
P calculated by χ2 (categorical data) and two-sided Student’s t-test with Welch’s procedure (continuous data with unequal variance).